manifestări extrahepatice în hepatitele cronice la copil - Gr.T. Popa
manifestări extrahepatice în hepatitele cronice la copil - Gr.T. Popa
manifestări extrahepatice în hepatitele cronice la copil - Gr.T. Popa
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
66. Zuckerman J, van Hattum J, Cafferkey M, Gjørup I, Hoel T, Rummukainen ML,<br />
Wei<strong>la</strong>nd O. Should hepatitis B vaccination be introduced into childhood<br />
immunisation programmes in northern Europe? Lancet Infect Dis. 2007<br />
Jun;7(6):410-9<br />
67. Ranger-Rogez, S., 2004, Hepatitis B mother--to--child transmission, Expert Rev<br />
Anti Infect Ther. 2004 Feb;2(1):133-45<br />
68. Rehermann B., 2005, Immunology of hepatitis B virus and hepatitis C virus<br />
infection, Nat Rev Immunol 5, 215-229 (March 2005), doi:10.1038/nri1573<br />
69. TJ Liang. The Current Status of HCV Vaccine Development. 13th International<br />
Symposium on Viral Hepatitis and Liver Disease (ISVHLD). Washington, DC.<br />
May 20-24, 2009<br />
70. Houghton M, Abrignani S. Prospects for a vaccine against the hepatitis C virus.<br />
Nature 436: 961-966. 3 M. Houghton, Abrignani S. 2005<br />
71. Reed SG, Bertholet S, Coler RN, Friede M. New horizons in adjuvants for<br />
vaccine development. Trends in Immunology . 5 SG. Reed, Bertholet S, Coler RN,<br />
Friede M. December 2, 2008<br />
72. Bowen DG, Walker CM. 4. Bowen DG, Walker CM. Adaptive immune responses<br />
in acute and chronic hepatitis C virus infection. Nature 436: 946-952.2005<br />
73. CJ Liu, JH Kao, DS Chen. Therapeutic implications of hepatitis B virus<br />
genotypes. Liver Int 2005; 25: 1097–107<br />
74. Chan HL, Heathcote, Marcellin P EJ, et al. Treatment of hepatitis B e antigen<br />
positive chronic hepatitis with telbivudine or adefovir: a randomized trial. Ann<br />
Intern Med 2007; 147: 745–54<br />
75. Hann HW, Chae HB, Dunn SR: Tenofovir (TDF) has stronger antiviral effect than<br />
adefovir (ADV) against <strong>la</strong>mivudine (LAM)-resistant hepatitis B virus<br />
(HBV).Hepatol Int 2008, 2:244-249<br />
76. Bortolotti F, Jara P, Barbera C, et al . Bortolotti F, P Jara, C Barbera, et al. Long<br />
term effect of alpha interferon in children with chronic hepatitis B. Gut 2000; 46:<br />
715–8<br />
77. Marx G, Martin SR, Chicoine JF, Alvarez F. Long-term follow-up of chronic<br />
hepatitis B virus infection in children of different ethnic origins. J Infect Dis<br />
2002; 186: 295–301<br />
78. Hsu HY, HY Tsai, TC Wu, et al. Interferon-alpha treatment in children and young<br />
adults with chronic hepatitis B: a long-term follow-up study in Taiwan. Liver Int<br />
2008; 28: 1288–97<br />
79. Narkewicz MR, Smith D, Silverman A, Vierling J, Sokol RJ.Clearance of chronic<br />
hepatitis B virus infection in young children after alpha interferon treatment. J<br />
Pediatr 1995; 127: 815–8<br />
80. Dixon JS, Boehme RE.Lamivudine for the treatment of chronic hepatitis B. Acta<br />
Gastro-Enterologica Belgica 2000; 63:348-56<br />
81. Jonas MM, Mizierski J, Badia IB, Areias JA, Schwarz KB, Little NR, et al .<br />
Clinical trial of <strong>la</strong>mivudine in children with chronic hepatitis B. NEJM,<br />
2002;3461706-13<br />
82. Hartman C, Berkowitz D, Shouval D, Eshach-Adiv O, Hino B, Rimon N, et al .<br />
Lamivudine treatment for chronic hepatitis B infection in children unresponsive to<br />
interferon.Pediatr Infect Dis J 2003; 22:224-9
Change language